SCNLF (Scancell Holdings) Effective Interest Rate on Debt %: 12.14% (As of Oct. 2025)


SCNLF Scancell Holdings PLC SCNLF
16 GF Score
Price $0.28
! 2 Warning Signs
View Full Analysis

What is Scancell Holdings Effective Interest Rate on Debt %?

Scancell Holdings SCNLF 16 Effective Interest Rate on Debt % is 12.14% as of Oct. 2025. GuruFocus rates SCNLF with a GF Score™ of 16/100. The stock has 2 warning signs investors should review.

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Scancell Holdings's annualized positive value of Interest Expense for the quarter that ended in Oct. 2025 was $2.61 Mil. Scancell Holdings's average total debt for the quarter that ended in Oct. 2025 was $21.49 Mil. Therefore, Scancell Holdings's annualized Effective Interest Rate on Debt % for the quarter that ended in Oct. 2025 was 12.14%.


Scancell Holdings  (OTCPK:SCNLF) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.


Scancell Holdings Effective Interest Rate on Debt % Related Terms


Scancell Holdings Effective Interest Rate on Debt % Historical Data

* Premium members only.

The historical data trend for Scancell Holdings's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Scancell Holdings Effective Interest Rate on Debt % Chart

Scancell Holdings Annual Data
Trend Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25
Effective Interest Rate on Debt %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.30 10.01 6.18 5.54 9.76

Scancell Holdings Semi-Annual Data
Apr16 Oct16 Apr17 Oct17 Apr18 Oct18 Apr19 Oct19 Apr20 Oct20 Apr21 Oct21 Apr22 Oct22 Apr23 Oct23 Apr24 Oct24 Apr25 Oct25
Effective Interest Rate on Debt % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.95 6.09 9.16 11.65 12.14

SCNLF vs VRTX, REGN, ALNY: Effective Interest Rate on Debt % Comparison

For the Biotechnology subindustry, Scancell Holdings's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Scancell Holdings Effective Interest Rate on Debt % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Scancell Holdings's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where Scancell Holdings's Effective Interest Rate on Debt % falls into.


SCNLF
16GF Score
Scancell Holdings PLC SCNLF
Effective Interest Rate on Debt % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Scancell Holdings Effective Interest Rate on Debt % Calculation

Scancell Holdings's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Apr. 2025 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (A: Apr. 2024 )+Total Debt  (A: Apr. 2025 ))/ count )
=-1  *  -2.256/( (24.864+21.376)/ 2 )
=-1  *  -2.256/23.12
=9.76 %

where

Total Debt  (A: Apr. 2024 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=22.318 + 2.546
=24.864

Total Debt  (A: Apr. 2025 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=0.162 + 21.214
=21.376

Scancell Holdings's annualized Effective Interest Rate on Debt % for the quarter that ended in Oct. 2025 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (Q: Apr. 2025 )+Total Debt  (Q: Oct. 2025 ))/ count )
=-1  *  -2.608/( (21.376+21.605)/ 2 )
=-1  *  -2.608/21.4905
=12.14 %

where

Total Debt  (Q: Apr. 2025 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=0.162 + 21.214
=21.376

Total Debt  (Q: Oct. 2025 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=0 + 21.605
=21.605

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is two times the semi-annual (Oct. 2025) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.

What does a Effective Interest Rate on Debt % of 12.14% mean?
Scancell Holdings (SCNLF) has a Effective Interest Rate on Debt % of 12.14% as of Oct. 2025. Effective interest rate on debt is the rate a company actually pays on its debt. View historical data on Scancell Holdings and its competitors.
Is Scancell Holdings' Effective Interest Rate on Debt % too high?
Scancell Holdings' current Effective Interest Rate on Debt % is 12.14%. Overall, Scancell Holdings has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Scancell Holdings' Effective Interest Rate on Debt % compare to VRTX and REGN?
Scancell Holdings' Effective Interest Rate on Debt % of 12.14% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Effective Interest Rate on Debt % for a Biotechnology company?
A good Effective Interest Rate on Debt % depends on the Biotechnology industry context. However, Effective Interest Rate on Debt % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Effective Interest Rate on Debt % mean?
A high Effective Interest Rate on Debt % can signal that a stock is expensive relative to its fundamentals. Effective interest rate on debt is the rate a company actually pays on its debt. View historical data on Scancell Holdings and its competitors. Scancell Holdings's current Effective Interest Rate on Debt % is 12.14%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scancell Holdings stock overvalued right now?
Scancell Holdings (SCNLF) has a current Effective Interest Rate on Debt % of 12.14%. The current Effective Interest Rate on Debt % is 12.14%. Scancell Holdings' overall GF Score™ is 16/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Effective Interest Rate on Debt % calculated?
Effective Interest Rate on Debt % is calculated from a company's financial statements. For Scancell Holdings (SCNLF), the current Effective Interest Rate on Debt % is 12.14% as of Oct. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Scancell Holdings Business Description

Other Exchanges SCLP:UKSCP:Germany
Address Sanders Road, Unit 202, Bellhouse Building, Oxford Science Park, Oxford, GBR, OX4 4GD
Scancell Holdings PLC is a clinical-stage biotechnology company developing targeted off-the-shelf active immunotherapies to generate safe and long-lasting tumour-specific immunity for a cancer-free future. iSCIB1+, a product from its DNA ImmunoBody platform (AvidiMab), has demonstrated safe, durable, and clinically meaningful benefit as a monotherapy as well as additional benefit when combined with checkpoint therapies in an ongoing Phase 2 trial in melanoma. Modi-1, the peptide immunotherapy from its Moditope platform, is being investigated in a Phase 2 study in a broad range of solid tumours. In addition, the company has established a subsidiary with the intention to hold and develop an early-stage pipeline of high-affinity GlyMab antibodies targeting tumour-specific glycans.
16GF Score

Get the complete analysis for SCNLF

Effective Interest Rate on Debt % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.28
Price